Observational studyBreast cancer (Tokyo, Japan)2025

Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.

Daniela Katz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.